Hainan Huluwa Pharmaceutical Group Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 575.553 million compared to CNY 610.801 million a year ago. Operating income was CNY 53.786 million compared to CNY 47.356 million a year ago. Net income was CNY 42.513 million compared to CNY 40.644 million a year ago. Basic earnings per share from continuing operations was CNY 0.12 compared to CNY 0.11 a year ago.